Search Results - "Salu, Philip"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Nanocarrier mediated entinostat and oxaliplatin combination therapy displayed enhanced efficacy against pancreatic cancer by Giri, Paras Mani, Kumar, Ashish, Salu, Philip, Sathish, Venkatachalem, Reindl, Katie, Mallik, Sanku, Layek, Buddhadev

    Published in Biomedicine & pharmacotherapy (01-06-2024)
    “…Pancreatic cancer is the third leading cause of cancer-related death in the United States, with a 5-year survival rate of only 12%. The poor prognosis of…”
    Get full text
    Journal Article
  2. 2

    Abstract LB192: AGR2 knockdown reduces cell proliferation and increases endoplasmic reticulum proteotoxic stress in pancreatic cancer by Salu, Philip, Reindl, Katie

    Published in Cancer research (Chicago, Ill.) (05-04-2024)
    “…Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal solid malignancy with low survival rates due to a dense stroma, abnormal gene expression…”
    Get full text
    Journal Article
  3. 3

    AGR2 knockdown induces ER stress and mitochondria fission to facilitate pancreatic cancer cell death by Salu, Philip, Tuvin, Daniel, Reindl, Katie M.

    “…Anterior gradient 2 (AGR2) is often overexpressed in many human cancers, including pancreatic ductal adenocarcinoma (PDAC). Elevated AGR2 expression is known…”
    Get full text
    Journal Article
  4. 4

    Advancements in Preclinical Models of Pancreatic Cancer by Salu, Philip, Reindl, Katie M

    Published in Pancreas (01-02-2024)
    “…Pancreatic cancer remains one of the deadliest of all cancer types with a 5-year overall survival rate of just 12%. Preclinical models available for…”
    Get more information
    Journal Article
  5. 5

    Mesenchymal stem cell-delivered paclitaxel nanoparticles exhibit enhanced efficacy against a syngeneic orthotopic mouse model of pancreatic cancer by Mani Giri, Paras, Banerjee, Anurag, Ghosal, Arpita, Salu, Philip, Reindl, Katie, Layek, Buddhadev

    Published in International journal of pharmaceutics (05-12-2024)
    “…[Display omitted] •Nano-MSCs were generated by incubating MSCs with drug-loaded nanoparticles.•Drug loading on MSCs was performed by endocytosis and surface…”
    Get full text
    Journal Article
  6. 6

    Advancements in Circulating Tumor Cell Research: Bridging Biology and Clinical Applications by Salu, Philip, Reindl, Katie M

    Published in Cancers (20-03-2024)
    “…Circulating tumor cells (CTCs) are cells released from the primary and metastatic tumor and intravasate into the blood or lymphatic vessels, where they are…”
    Get full text
    Journal Article